On Monday, the Federal Register published two final rules from the U.S. Department of Justice (DOJ) and Department of Health & Human Services (HHS) titled “Expansion of Buprenorphine Treatment via Telemedicine Encounter” and “Continuity of Care via Telemedicine for Veterans Affairs Patients.” Originally scheduled to go into effect on March 21, 2025, the rules were delayed by a “Regulatory Freeze Pending Review.” Following comments from the public received by the DOJ’s Drug Enforcement Agency, the effective date of both final rules is moved to December 31, 2025.
